The present invention is based upon the identification of several genes that either enhance or suppress Tau-related neurodegeneration when expressed. These may be used in diagnostic assays and in assays designed to find factors that may be used to treat neurological diseases, such as Alzheimer's disease.
GENES AND PROTEINS ALTERING TAU-RELATED NEURODEGENERATION